PUMA BIOTECHNOLOGY, INC.·4

Jul 8, 8:21 PM ET

AUERBACH ALAN H 4

4 · PUMA BIOTECHNOLOGY, INC. · Filed Jul 8, 2026

Research Summary

AI-generated summary of this filing

Updated

PUMA BIOTECH (PBYI) 10% Owner Alan H. Auerbach Sells Shares

What Happened

Alan H. Auerbach, listed as a 10% owner of Puma Biotechnology, sold 44,058 shares of PBYI on July 6, 2026. The shares were disposed at $8.26 per share for a total transaction value of $364,051. The sale is reported as an open-market or private sale (transaction code S).

Key Details

  • Transaction date and price: July 6, 2026 — 44,058 shares at $8.26 per share.
  • Total value: $364,051.
  • Shares owned after transaction: Not disclosed in the filing.
  • Footnote: The sale is referenced under a 10b5-1(c) "sell to cover" program adopted on 12-17-2020 (per footnote F1).
  • Filing timeliness: Form 4 was filed on July 8, 2026 (appears timely — within the required two business days).

Context

  • This was a sale (S), not a purchase; sales by insiders can be routine and do not necessarily indicate a change in company prospects.
  • The transaction is tied to a 10b5-1 plan, which typically means the sale was preplanned and executed according to that program's terms.

Insider Transaction Report

Form 4
Period: 2026-07-06
AUERBACH ALAN H
DirectorPresident and CEO10% Owner
Transactions
  • Sale

    Common Stock

    [F1]
    2026-07-06$8.26/sh44,058$364,0517,261,671 total
Footnotes (1)
  • [F1]Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2020.
Signature
/s/ Gordon Esplin as attorney-in-fact for Alan H. Auerbach|2026-07-08

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4